A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
Clinical trial NCT04704154 · COMPLETED
Trial details
- NCT number
- NCT04704154
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2023-03-09
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.